These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7906914)

  • 21. Disappearance of hepatic encephalopathy and improvement of liver function after surgical treatment of portal-systemic shunt in a patient with liver cirrhosis.
    Moriya K; Kojima H; Matsumura M; Sakurai S; Imazu H; Uemura M; Honda H; Fukui H
    Hepatogastroenterology; 2003; 50(52):1128-32. PubMed ID: 12845996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postural control in patients with liver cirrhosis: a posturographic study.
    Schmid M; Mittermaier C; Voller B; Fialka-Moser V; Gangl A; Peck-Radosavljevic M
    Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):915-22. PubMed ID: 19242358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical management of hepatic encephalopathy.
    Schiano TD
    Pharmacotherapy; 2010 May; 30(5 Pt 2):10S-5S. PubMed ID: 20412035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ammonia levels and the severity of hepatic encephalopathy.
    Qureshi MO; Khokhar N; Shafqat F
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):160-3. PubMed ID: 24613109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
    Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
    Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic encephalopathy: pathophysiology and emerging therapies.
    Sundaram V; Shaikh OS
    Med Clin North Am; 2009 Jul; 93(4):819-36, vii. PubMed ID: 19577116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hyperammonemia and hepatic encephalopathy in cirrhotics receiving spironolactone (author's transl)].
    Imler M; Schlienger JL
    Nouv Presse Med; 1977 Nov; 6(37):3407-10. PubMed ID: 600713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral blood flow in basal ganglia is correlated with clinical signs of hepatic encephalopathy in patients with liver cirrhosis.
    Iwasa M; Kaito M; Adachi Y; Watanabe Y; Matsumura K; Takeda K
    Am J Gastroenterol; 2002 Mar; 97(3):763-4. PubMed ID: 11922581
    [No Abstract]   [Full Text] [Related]  

  • 30. [Abnormal TSH, PRL and GH response to TSH releasing hormone in patients with severe liver cirrhosis (proceedings) (author's transl)].
    Schilienger JL; Jacques C; Demangeat C; Sapin R; Imler M
    Ann Endocrinol (Paris); 1978; 39(3):245-7. PubMed ID: 102237
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatic encephalopathy as a complication of liver cirrhosis: an Asian perspective.
    Moriwaki H; Shiraki M; Iwasa J; Terakura Y
    J Gastroenterol Hepatol; 2010 May; 25(5):858-63. PubMed ID: 20546438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic encephalopathy: a critical current review.
    Hadjihambi A; Arias N; Sheikh M; Jalan R
    Hepatol Int; 2018 Feb; 12(Suppl 1):135-147. PubMed ID: 28770516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent developments in the pathophysiology and treatment of hepatic encephalopathy.
    Weissenborn K
    Baillieres Clin Gastroenterol; 1992 Sep; 6(3):609-30. PubMed ID: 1358278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation.
    Senzolo M; Amodio P; D'Aloiso MC; Fagiuoli S; Del Piccolo F; Canova D; Masier A; Bassanello M; Zanus G; Burra P
    Transplant Proc; 2005 Mar; 37(2):1104-7. PubMed ID: 15848636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatic encephalopathy].
    Kaku T; Shiba M; Yoshimasu F
    Nihon Rinsho; 2004 Jan; 62 Suppl():409-13. PubMed ID: 15011396
    [No Abstract]   [Full Text] [Related]  

  • 36. Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure.
    Kristiansen RG
    Metab Brain Dis; 2016 Dec; 31(6):1357-1358. PubMed ID: 27651377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The so called hepatic encephalopathy. Pathophysiology and diagnosis].
    Spatz R; Kollmannsberger A
    Munch Med Wochenschr; 1971 Sep; 113(39):1250-4. PubMed ID: 5171156
    [No Abstract]   [Full Text] [Related]  

  • 38. [Ammonia as a cause for hepatic encephalopathy].
    Naimushin A; Livneh A
    Harefuah; 2010 Feb; 149(2):113-4, 123. PubMed ID: 20549931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ammonia and hepatic encephalopathy: the more things change, the more they remain the same.
    Shawcross DL; Olde Damink SW; Butterworth RF; Jalan R
    Metab Brain Dis; 2005 Sep; 20(3):169-79. PubMed ID: 16167195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vigilance and wake EEG architecture in simulated hyperammonaemia: a pilot study on the effects of L-Ornithine-L-Aspartate (LOLA) and caffeine.
    Garrido M; Skorucak J; Raduazzo D; Turco M; Spinelli G; Angeli P; Amodio P; Achermann P; Montagnese S
    Metab Brain Dis; 2016 Aug; 31(4):965-74. PubMed ID: 27193025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.